Distanct ischemic postconditioning in acute mild to moderate ischemic stroke: A randomized clinical study

Area of Science:

• Neurology
• Cardiovascular Research

Background:

• Distant ischemic postconditioning (DIPC) demonstrates neuroprotective effects in animal ischemia models.
• Clinical evidence for DIPC's efficacy and safety in humans remains limited.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of DIPC in patients with acute non-cardiogenic mild to moderate cerebral infarction.
• To assess DIPC's impact on neurological deficits and compare it with standard care.

Main Methods:

• 86 patients with acute cerebral infarction were divided into DIPC and control groups.
• DIPC therapy was administered using different pressure settings over 7 days.
• Neurological assessments included NIHSS and modified Rankin scale, with platelet aggregation rates monitored.

Main Results:

• DIPC group showed significant improvement in NIHSS scores and modified Rankin scale after 7 days.
• A significant difference in NIHSS score reduction was observed between DIPC and control groups on day 8.
• No significant changes in early neurological deterioration or platelet aggregation rates were noted between groups.

Conclusions:

• DIPC is a safe and effective treatment for improving neurological deficits in the acute phase of mild to moderate cerebral infarction.
• DIPC does not interfere with the effectiveness of antiplatelet medications.
• Further clinical studies are warranted to solidify DIPC's role in stroke management.